Bristol-Myers Squibb Up 1% on New Drug Applications BioPharma Consumer Cyclicals Diversified Financial Macro Markets Software & ServicesApril 14, 2014 Recently, Bristol-Myers Squibb (BMY) submitted new drug applications to the U.S. Food and Drug Administration (FDA). Sharing Twitter0 Facebook0 Google +0 Linkedinactive){li-icon[type=linkedin-bug][color=inverse] .background{fill Email this article Print this article Tags BMY, Bristol-Myers Squibb, FDA, NS5A, U.S. Food and Drug Administration